Showing results (201-210 of 662) with videos related to

Sort By:
Pageof 67
Neurology|April 11, 2001
Cocaine-induced persistent dyskinesiasW J Weiner, A Rabinstein, B Levin, et al.
Parkinsonism & Related Disorders|June 1, 2002
Non-recognition of depression and other non-motor symptoms in Parkinson's diseaseL M Shulman, R L Taback, A A Rabinstein, et al.
Neurology|November 1, 1978
Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonismP A Nausieda, W J Weiner, D J Kanapa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Hemichorea-hemiballismus associated with acquired immune deficiency syndrome and cerebral toxoplasmosisJ R Sanchez-Ramos, S A Factor, W J Weiner, et al.
Neurology|October 1, 1978
Gilles de la Tourette syndrome after long-term chlorpromazine therapyH L Klawans, D K Falk, P A Nausieda, et al.
Neurology|April 1, 1993
Levodopa, melanoma, and Parkinson's diseaseW J Weiner, C Singer, J R Sanchez-Ramos, et al.
Annals of Neurology|September 1, 1996
Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's diseaseN Diederich, C Hilger, C G Goetz, et al.
Clinical Neuropharmacology|June 1, 1993
Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystoniaA S Buchman, C L Comella, G T Stebbins, et al.
Neurology|August 1, 1989
Agonist substitution in advanced Parkinson's diseaseC G Goetz, K M Shannon, C M Tanner, et al.
Neurology|May 1, 1987
Parkinson's disease and motor fluctuations: long-acting carbidopa/levodopa (CR-4-Sinemet)C G Goetz, C M Tanner, H L Klawans, et al.
Pageof 67